Thymidylate synthase and microsatellite instability in colorectal cancer: Implications for disease free survival, treatment response and survival with metastases

References

• Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481–8
   PubMed Web of Science ®Google Scholar
• Gonen M, Hummer A, Zervoudakis A, Sullivan D, Fong Y, Banerjee D., et al. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol 2003; 21: 406–12
   PubMed Web of Science ®Google Scholar
• Suda Y, Kuwashima Y, Tanaka Y, Uchida K, Akazawa S. Immunohistochemical detection of thymidylate synthase in advanced gastric cancer: A prognostic indicator in patients undergoing gastrectomy followed by adjuvant chemotherapy with 5-fluoropyrimidines. Anticancer Res 1999; 19: 805–10
   PubMedGoogle Scholar
• Suzuki M, Tsukagoshi S, Saga Y, Ohwada M, Sato I. Enhanced expression of thymidylate synthase may be of prognostic importance in advanced cervical cancer. Oncology 1999; 57: 50–4
   PubMedGoogle Scholar
• Jones AM, Douglas EJ, Halford SE, Fiegler H, Gorman PA, Roylance RR., et al. Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 2005; 24: 118–29
   PubMed Web of Science ®Google Scholar
• Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA., et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res 1994; 54: 4308–12
   PubMed Web of Science ®Google Scholar
• Sinicrope FA, Rego RL, Halling KC, Foster NR, Sargent DJ, La Plant B., et al. Thymidylate synthase expression in colon carcinomas with microsatellite instability. Clin Cancer Res 2006; 12: 2738–44
   PubMed Web of Science ®Google Scholar
• Ricciardiello L, Ceccarelli C, Angiolini G, Pariali M, Chieco P, Paterini P., et al. High thymidylate synthase expression in colorectal cancer with microsatellite instability: Implications for chemotherapeutic strategies. Clin Cancer Res 2005; 11: 4234–40
   PubMedGoogle Scholar
• Popat S, Wort R, Houlston RS. Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: Implications for chemoresistance. BMC Cancer 2006; 6: 150
   PubMedGoogle Scholar
• Glimelius B, Ristamaki R, Kjaer M, Pfeiffer P, Toren JS, Tveit KM, et al. Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first line therapy in advanced colorectal cancer. Ann Oncol 2002; 13: 1868–73
   PubMed Web of Science ®Google Scholar
• Peters GJ, van der Wilt CL, van Groeningen CJ, Smid K, Meijer S, Pinedo HM. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: Implications for treatment with fluorouracil. J Clin Oncol 1994; 12: 2035–42
   PubMed Web of Science ®Google Scholar
• Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994; 12: 2640–7
   PubMed Web of Science ®Google Scholar
• Lenz HJ, Hayashi K, Salonga D, Danenberg KD, Danenberg PV, Metzger R, et al. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival. Clin Cancer Res 1998; 4: 1243–50
   PubMed Web of Science ®Google Scholar
• Lenz HJ, Danenberg KD, Leichman CG, Florentine B, Johnston PG, Groshen S, et al. p53 and thymidylate synthase expression in untreated stage II colon cancer: Associations with recurrence, survival, and site. Clin Cancer Res 1998; 4: 1227–34
   PubMed Web of Science ®Google Scholar
• Yamachika T, Nakanishi H, Inada K, Tsukamoto T, Kato T, Fukushima M, et al. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer 1998; 82: 70–7
   PubMed Web of Science ®Google Scholar
• Edler D, Hallstrom M, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res 2000; 6: 1378–84
   PubMedGoogle Scholar
• Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995; 55: 1407–12
   PubMed Web of Science ®Google Scholar
• Leichman L, Lenz HJ, Leichman CG, Groshen S, Danenberg K, Baranda J, et al. Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial. Eur J Cancer 1995; 31A: 1306–10
   PubMed Web of Science ®Google Scholar
• Bendardaf R, Lamlum H, Elzagheid A, Ristamaki R, Pyrhonen S. Thymidylate synthase expression levels: A prognostic and predictive role in advanced colorectal cancer. Oncol Rep 2005; 14: 657–62
   PubMedGoogle Scholar
• Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, et al. Instabilotyping: Comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res 2001; 61: 6046–9
   PubMedGoogle Scholar
• Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol 2002; 3: 83–8
   PubMed Web of Science ®Google Scholar
• Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, et al. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998; 58: 1713–8
   PubMed Web of Science ®Google Scholar
• Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455–60
   PubMed Web of Science ®Google Scholar
• Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997; 57: 808–11
   PubMed Web of Science ®Google Scholar
• Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643–9
   PubMed Web of Science ®Google Scholar
• Halford S, Sasieni P, Rowan A, Wasan H, Bodmer W, Talbot I, et al. Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res 2002; 62: 53–7
   PubMed Web of Science ®Google Scholar
• Liang JT, Huang KC, Lai HS, Lee PH, Cheng YM, Hsu HC, et al. High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection. Int J Cancer 2002; 101: 519–25
   PubMedGoogle Scholar
• Rosty C, Chazal M, Etienne MC, Letoublon C, Bourgeon A, Delpero JR, et al. Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: Relationship with response to 5-fluorouracil and survival. Int J Cancer 2001; 95: 162–7
   PubMedGoogle Scholar
• Elsaleh H, Iacopetta B. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma. Clin Colorectal Cancer 2001; 1: 104–9
   PubMedGoogle Scholar
• Hemminki A, Mecklin JP, Jarvinen H, Aaltonen LA, Joensuu H. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000; 119: 921–8
   PubMed Web of Science ®Google Scholar
• Sobin LH, Greene FL. TNM classification: clarification of number of regional lymph nodes for pNo. Cancer 2001; 92: 452
   PubMed Web of Science ®Google Scholar